Skip to main content
GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System

GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System

Outcomes are everything for your TEVAR patients. Which is why our latest innovation that offers you high levels of control is supported by more than 20 years of TEVAR experience and clinical data from a broad range of studies.

Long-term results you can trust

U.S. Pivotal Clinical Trials: Five year data across ALL etiologies.

U.S. IDE Clinical Trials: Five year data across ALL etiologies.

Real-world data

SURPASS Registry results

Graphic with real world data

GREAT data highlights through three years1 across ALL etiologies

GREAT Registry Results graphic

Time-tested innovation

time-tested innovation graphic

Contact your Gore representative to discuss case planning or training needs:

Email MPDTempeSalesSupport@wlgore.com

Call 800-469-6999, or Request contact

* Migrations are reported as those requiring reintervention.

Rates are based on physician experience as reported for 127 subjects in Europe within a 30 day follow-up period. European-Post Approval Registry: Observational Registry Characterizing the Performance and Feature Use of the GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System. (data on file 2017; W.L. Gore & Associates, Inc; Flagstaff, AZ.)

Note: Only serious endoleaks are reported in GREAT (i.e., requiring reintervention).

§ Data on file; W.L. Gore & Associates, Inc.; Flagstaff, AZ.

  1. W. L. Gore & Associates. 'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation. Bethesda, MD: National Library of Medicine; 2012. Available from: NLM Identifier: NCT01658787. Published August 7, 2012. Updated: September 29, 2021. Accessed June 7, 2022. https://clinicaltrials.gov/ct2/show/NCT01658787

Related to this product

22620715-EN